William Douglas Figg, Sr.

Dr. William Douglas Figg, Sr. is an American pharamacollgist. He is the chief of the Molecular and Clinical Pharmacology Program at the National Cancer Institute, National Institutes of Health. His laboratory and clinic at the NCI have focused on the development of angiogenesis inhibitors. Dr. Figg has published more than 380 publications.